OptimizeRx Corp — Director's Dealing 2024

Jun 11, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-06-05

Reporting Person: HALAS GUS D (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-06-05	Common Stock	M	10061	—	Acquired	80926	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-05	Restricted Stock Units	$	M	10061	Disposed		Common Stock (10061)	Direct

Footnotes

F1: Restricted stock units convert into common stock on a one-for-one basis.

F2: On June 7, 2023 the reporting person was granted 10,061 restricted stock units which vested in full on June 5, 2024.